MethAZOLAMIDE Chew Treat
MethAZOLAMIDE is a compounded formulation containing MethAZOLAMIDE, prepared by Mixlab for veterinary use. Available by prescription.
Chew treats are flavored, soft treats that contain your pet’s medication—making giving meds as easy as offering a snack!
Use as directed by your veterinarian.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Methazolamide is a carbonic anhydrase inhibitor utilized in veterinary medicine for localized and systemic management of fluid pressure. It is a prescription medication available for use in dogs and cats, frequently considered by veterinarians for patients presented with glaucoma where managing intraocular pressure is a primary clinical objective. Your veterinarian will determine appropriateness based on an ophthalmic examination and tonometry.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, it is considered to influence the production of aqueous humor by inhibiting the enzyme carbonic anhydrase. Commonly observed effects include localized digestive changes such as vomiting, as well as behavioral shifts like temporary lethargy or coordination changes (ataxia). Because it can influence acid-base balance and electrolyte status, your veterinarian will monitor for observational signs of sensitivity through periodic blood tests. Owners should monitor for significant changes in breathing patterns or energy and contact their veterinarian promptly.
Yes. Methazolamide is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all legal requirements before any medication is prepared or shipped.
Yes. Mixlab specializes in compounding methazolamide into customized strengths and flavored oral formats, such as flavored oral liquids or capsules, to suit the specific needs of your pet.
Veterinarians discuss methazolamide for glaucoma because it is considered to influence the volume of fluid produced inside the eye. By influencing this production, it provides a method for addressing intraocular pressure.
Commonly observed effects include lethargy or a decrease in appetite. If you notice your pet appearing unusually weak or panting excessively, contact your veterinarian immediately for a clinical review.
While related to topical medications, methazolamide is an oral medication that is considered to address eye pressure systemically. Your veterinarian will determine if an oral format or a topical drop is best for your pet.
